Cite

HARVARD Citation

    Fukahori, M. et al. (2021). A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancer. Medicine. 100 (20), p. . [Online]. 
  
Back to record